Market cap
$1.5m
End-of-day close multiplied by current shares on issue.
Result releasedAnnolyse analysis published
Exact source statement comparison; reported operating, profit and cash-flow bases retained.
Revenue context before the current result.
Operating cash flow across covered periods.
Statutory profit after tax across covered periods.
Return on equity across covered periods.
Market context
These ratios pair a market close from around the result date with verified filing data. An unavailable metric means the required inputs were missing or unsuitable for comparison.
The latest close and share count context for the market price.
Market cap
$1.5m
End-of-day close multiplied by current shares on issue.
How the market price compares with recent earnings and cash-flow inputs.
P/E
Not available
Not meaningful when recent earnings are negative.
EPS
-0.00
Recent filing-derived earnings per share.
PEG
Not available
Not available for this company right now.
EV/EBITDA
Not available
Not meaningful when recent EBITDA is negative.
P/FCF
Not available
Not meaningful when free cash flow is negative or unavailable.
P/B
28.61x
Market value compared with latest reported equity.
Yield and investment-company valuation where supported.
Dividend yield
0.0%
Trailing dividends compared with the latest close.
Total return
Not available
Available once dividend and adjustment data are verified.
Key metrics
FY24 vs FY23
Revenue
$0m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
EBITDA
−$0.8m
-186.8% ↓ vs −$0.28m
Net profit after tax
−$0.8m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Net cash inflow from operating activities
−$0.73m
-77.7% ↓ vs −$0.41m
Profit before tax
−$0.8m
Suppressed: metric quality flags mark this value as unsuitable for normal comparison.
Cash and cash equivalents
$0.17m
-55.8% ↓ vs $0.38m
Total assets
$0.9m
-48.3% ↓ vs $1.7m
Analysis ofIPR FY24Result releasedAnnolyse analysis published
What changed
The NZX form reports no revenue; the income statement separately reports interest income of NZ$41,396, compared with NZ$26,121.
| NZ$ | FY24 | FY23 |
|---|---|---|
| Deposit interest income | 41,396 | 26,121 |
| Administrative expenses | 344,372 | 306,197 |
| Outsourced manufacturing plant expenses | 500,000 | — |
| Loss before tax and net loss | n/m | n/m |
What matters
The increase in interest income only partly offsets those expenses. Depreciation, amortisation and impairment of NZ$9,283 sits below the statement's NZ$802,976 loss-before-interest subtotal; the NZ$41,396 interest income is already included above that subtotal and must not be added again.
Assets fell to NZ$898,511 from NZ$1,737,758. Equity was NZ$814,081, compared with NZ$1,626,340. Cash and cash equivalents were NZ$168,647 and term deposits NZ$691,074; those are separate balances.
Expectations
Their stated licence targets are five Pathoglaze customers and at least SGD150,000 of revenue in the twelve months to September 2025, increasing to SGD1,000,000 by September 2026. These are targets, not sales demonstrated by this preliminary result.
Quality of result
Maturing term deposits provided NZ$520,737, partly offset by NZ$9,284 of intangible purchases, leaving NZ$511,453 of investing inflow. Cash fell by NZ$213,467. A deposit maturity changes the form of liquid assets; it is not operating revenue.
The statements are preliminary and unaudited. The NZX form says the company does not propose a dividend.
Unresolved
This briefing cannot assess future customer conversions, licence-target delivery or funding availability from these preliminary statements.
Chat
Ask follow-up questions about Iperion's FY24 result.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Informational only. No buy, sell, hold, price-target, or personal financial advice.
Open to load analytical metrics.
Open to load key metrics.
Iperion: exact FY24 statement column
FY24 / financial reportIperion: exact FY23 statement column
FY23 / financial reportRelated insights
Compare this result's metrics with other covered NZX companies.
Get the next Iperion briefing and related NZX reporting-season updates by email.